Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2015

May 12, 2015

30583_dirs_2015-05-12_e023c3a1-09fd-4c23-a335-c5c0227eb626.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-04-30

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-04-30 Common Stock A 389 $51.2635 Acquired 110089 Direct
2015-04-30 Common Stock G 389 Disposed 109700 Direct
2015-04-30 Common Stock G 389 Acquired 24324 Indirect
2015-05-08 Common Stock G 1912 Disposed 107788 Direct
2015-05-08 Common Stock G 1912 Acquired 26236 Indirect
2015-05-08 Common Stock F 2088 $121.66 Acquired 105700 Direct

Footnotes

F1: The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the purchase period of November 1, 2014 to April 30, 2015.

F2: On April 30, 2015 the reporting person gifted 389 shares of Common Stock to his family trust. The reporting person is the trustee.

F3: On May 8, 2015 the reporting person gifted 389 shares of Common Stock to his family trust. The reporting person is the trustee.